In stark contrast, for the transcriptome in CER, which possesses a distinct cellular architecture and is comparatively spared by Alzheimer’s disease neuropathology, the subjects’ locations are randomly distributed along the trajectory. Here, CBLN1 is linked to early-onset autosomal dominant Alzheimer disease.